ESPERTI PHARMACEUTICALS
DEAD

Serial Number

90772225

Owner

Esperti Pharmaceuticals, LLC

Attorney

Matthew J. Himich

Filing Date

Jun 14, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ESPERTI PHARMACEUTICALS Trademark

Serial Number: 90772225

ESPERTI PHARMACEUTICALS is a trademark filed by Esperti Pharmaceuticals, LLC on June 14, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Esperti Pharmaceuticals, LLC

1196 Wicklow Road
Ballwin, MO 63021

Entity Type: 16

Trademark Details

Filing Date

June 14, 2021

Registration Date

Not Registered

Goods & Services

Consulting services in the field of pharmaceuticals and biotechnology research and development; consulting services for others in the field of design, planning, support and implementation of programs for scientific research of pharmaceuticals, laboratory testing of pharmaceuticals, diagnostics for pharmaceuticals, clinical trials of pharmaceuticals, testing, modeling and simulation of pharmaceuticals, and due diligence and audit of such programs; quality management services, namely quality evaluation and analysis, quality assurance, and quality control in the field of pharmaceutical drug manufacturing and contract manufacturing; consulting pertaining to pharmacokinetics and biostatistics; conducting scientific feasibility studies

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 16, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 16, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 16, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 11, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 11, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 11, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 6, 2022 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 1, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 31, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 5, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 5, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 5, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 4, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 1, 2021 NWOS
NEW APPLICATION ENTERED
Jun 17, 2021 NWAP